(Q48911961)

16 February 2018

title

Cyclosporine-associated organic mental disorders in liver transplant recipients. (English)

1 reference

16 February 2018

author name string

Craven JL

series ordinal

1

1 reference

16 February 2018

publication date

1 January 1991

1 reference

16 February 2018

published in

Psychosomatics

1 reference

16 February 2018

volume

32

1 reference

16 February 2018

page(s)

94-102

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

Cyclosporine: a new immunosuppressive agent for organ transplantation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Action and toxicity of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Severe central-nervous-system toxicity associated with cyclosporin.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Cyclosporine-associated central nervous system toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

NEUROLOGICAL COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Cyclosporin-associated cerebral lesions in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Association between cyclosporin neurotoxicity and hypomagnesaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Cyclosporin-associated fatal convulsions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Cerebral blindness and encephalopathy with cyclosporin A toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

TOXICITY OF CYCLSPORIN METABOLITES

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Complex visual hallucinations and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Methylphenidate for cyclosporine-associated organic mood disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Cyclosporin metabolites and central-nervous-system toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Central nervous system toxicity of cyclosporine in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

1 reference

7 January 2021

Cyclosporin A, methylprednisolone, and convulsions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Rejection encephalopathy. An acute neurological syndrome complicating renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Hypertension and convulsions in children receiving cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Cyclosporin encephalopathy associated with fat embolism induced by the drug's solvent

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Reconciling silent psychoses accompanying medical or surgical problems

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Blocking of cyclosporine immunosuppression by neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Convulsions associated with cyclosporin A in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Cyclosporine-associated central nervous system toxicity after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

Liver transplantation: psychiatric considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972117-8

7 January 2021

10.1016/S0033-3182(91)72117-8

Identifiers

DOI

0 references

PubMed ID

2003144

1 reference

16 February 2018